AXIRON DIN 02382369
Health Canada record
| Active ingredient(s) | TESTOSTERONE 30 MG |
|---|---|
| Dosage form | Solution |
| Route | Transdermal |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Human |
| ATC | G03BA03 TESTOSTERONE |
| Original market date | 08-May-2013 |
| Current status date | 04-Dec-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eli Lilly Canada Inc. — licence 100164, currently licensed, last inspection rating C (2026-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TESTOSTERONE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02245345 | ANDROGEL | BGP PHARMA ULC | Gel | TESTOSTERONE 1 % | Marketed |
| 02249499 | ANDROGEL | BGP PHARMA ULC | Gel | TESTOSTERONE 12.5 MG | Marketed |
| 02245346 | ANDROGEL | BGP PHARMA ULC | Gel | TESTOSTERONE 1 % | Marketed |
| 02450550 | NATESTO | ACERUS BIOPHARMA INC | Gel | TESTOSTERONE 4.5 % | Marketed |
| 02463806 | TARO-TESTOSTERONE GEL | TARO PHARMACEUTICALS INC | Gel | TESTOSTERONE 1 % | Marketed |
| 02463792 | TARO-TESTOSTERONE GEL | TARO PHARMACEUTICALS INC | Gel | TESTOSTERONE 1 % | Marketed |
| 02280248 | TESTIM 1% | KNIGHT THERAPEUTICS INC. | Gel | TESTOSTERONE 1 % | Marketed |
| 02245972 | ANDRODERM | ALLERGAN INC | Patch | TESTOSTERONE 5 MG | Cancelled Post Market |
| 02239653 | ANDRODERM | ALLERGAN INC | Patch | TESTOSTERONE 2.5 MG | Cancelled Post Market |
| 02027046 | MALOGEN AQUEOUS 100 SUS 100MG/ML | GERMIPHENE CORPORATION | Suspension | TESTOSTERONE 100 MG | Cancelled Post Market |
| 00477133 | TESTOS 100 INJ 100MG/ML | VETCOM 1979 INC. | Liquid | TESTOSTERONE 100 MG | Cancelled Post Market |
| 00616931 | UNI TEST SUSP 100MG/ML | UNIVET PHARMACEUTICALS LTD. | Suspension | TESTOSTERONE 100 MG | Cancelled Post Market |
| 02040964 | VETO-TEST (TESTOSTERONE INJECTABLE SUSPENSION) | VETOQUINOL N A INC | Suspension | TESTOSTERONE 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 13190 | 2012-04-05 | New Drug Submission (NDS) |
International API supply for TESTOSTERONE
7 valid EDQM Certificates of Suitability from 6 holders. 38 active FDA Drug Master Files.
Request a quote for AXIRON